659 words
Aveva Drug Delivery systems (A DifGen company) Announces First FDA Approval of Generic Lidocaine 1.8% Patch for the Treatment of Nerve Pain
News provided by Aveva Drug Delivery Systems Inc Mar 26, 2025, 09:30 ET MIRAMAR, Fla., March 26, 2025 /PRNewswire/ -- Aveva Drug Delivery systems (A DifGen company), a leader in transdermal drug delivery systems based out of Miramar - Florida is proud to announce that the U.S. Food…